143 related articles for article (PubMed ID: 28888173)
1. LC-MS/MS assay for the quantitation of the ATR kinase inhibitor VX-970 in human plasma.
Kiesel BF; Scemama J; Parise RA; Villaruz L; Iffland A; Doyle A; Ivy P; Chu E; Bakkenist CJ; Beumer JH
J Pharm Biomed Anal; 2017 Nov; 146():244-250. PubMed ID: 28888173
[TBL] [Abstract][Full Text] [Related]
2. LC-MS/MS assay for the simultaneous quantitation of the ATM inhibitor AZ31 and the ATR inhibitor AZD6738 in mouse plasma.
Kiesel BF; Shogan JC; Rachid M; Parise RA; Vendetti FP; Bakkenist CJ; Beumer JH
J Pharm Biomed Anal; 2017 May; 138():158-165. PubMed ID: 28213176
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of the ataxia-telangiectasia-mutated and Rad3-related inhibitor elimusertib (BAY-1895344) in human plasma using LC-MS/MS.
Kiesel BF; Parise RA; Krishnamurthy A; Gore S; Beumer JH
Biomed Chromatogr; 2022 Nov; 36(11):e5455. PubMed ID: 35876841
[TBL] [Abstract][Full Text] [Related]
4. LC-MS/MS assay for the quantitation of the ribonucleotide reductase inhibitor triapine in human plasma.
Matsumoto J; Kiesel BF; Parise RA; Guo J; Taylor S; Huang M; Eiseman JL; Ivy SP; Kunos C; Chu E; Beumer JH
J Pharm Biomed Anal; 2017 Nov; 146():154-160. PubMed ID: 28881312
[TBL] [Abstract][Full Text] [Related]
5. LC-MS/MS assay for the quantitation of the tyrosine kinase inhibitor neratinib in human plasma.
Kiesel BF; Parise RA; Wong A; Keyvanjah K; Jacobs S; Beumer JH
J Pharm Biomed Anal; 2017 Feb; 134():130-136. PubMed ID: 27907855
[TBL] [Abstract][Full Text] [Related]
6. LC-MS/MS assay for the quantitation of the HDAC inhibitor belinostat and five major metabolites in human plasma.
Kiesel BF; Parise RA; Tjørnelund J; Christensen MK; Loza E; Tawbi H; Chu E; Kummar S; Beumer JH
J Pharm Biomed Anal; 2013; 81-82():89-98. PubMed ID: 23644904
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a sensitive, fast and simple LC-MS / MS method for the quantitation of favipiravir in human serum.
Eryavuz Onmaz D; Abusoglu S; Onmaz M; Yerlikaya FH; Unlu A
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1176():122768. PubMed ID: 34052564
[TBL] [Abstract][Full Text] [Related]
8. LC-MS/MS assay for the quantitation of FdCyd and its metabolites FdUrd and FU in human plasma.
Holleran JL; Eiseman JL; Parise RA; Kummar S; Beumer JH
J Pharm Biomed Anal; 2016 Sep; 129():359-366. PubMed ID: 27454087
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of Cabozantinib in Human Plasma by LC-MS/MS.
Jones R; Holleran J; Parise RA; Rudek MA; Chan J; Wen Y; Gobburu J; Lewis LD; Beumer JH
J Chromatogr Sci; 2022 Mar; 60(3):274-279. PubMed ID: 34240176
[TBL] [Abstract][Full Text] [Related]
11. Rational Design of 5-(4-(Isopropylsulfonyl)phenyl)-3-(3-(4-((methylamino)methyl)phenyl)isoxazol-5-yl)pyrazin-2-amine (VX-970, M6620): Optimization of Intra- and Intermolecular Polar Interactions of a New Ataxia Telangiectasia Mutated and Rad3-Related (ATR) Kinase Inhibitor.
Knegtel R; Charrier JD; Durrant S; Davis C; O'Donnell M; Storck P; MacCormick S; Kay D; Pinder J; Virani A; Twin H; Griffiths M; Reaper P; Littlewood P; Young S; Golec J; Pollard J
J Med Chem; 2019 Jun; 62(11):5547-5561. PubMed ID: 31074988
[TBL] [Abstract][Full Text] [Related]
12. Liquid chromatography-tandem mass spectrometry based method development and validation of S016-1271 (LR8P), a novel cationic antimicrobial peptide for its application to pharmacokinetic studies.
Puttrevu SK; Laxman TS; Tripathi AK; Yadav AK; Verma SK; Mishra A; Pradhan R; Verma NK; Ghosh JK; Bhatta RS
J Pharm Biomed Anal; 2019 May; 169():116-126. PubMed ID: 30851514
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of iohexol, a glomerular filtration marker, in human plasma by LC-MS/MS.
Holleran JL; Parise RA; Guo J; Kiesel BF; Taylor SE; Ivy SP; Chu E; Beumer JH
J Pharm Biomed Anal; 2020 Sep; 189():113464. PubMed ID: 32659569
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a highly sensitive LC-ESI-MS/MS method for estimation of IIIM-MCD-211, a novel nitrofuranyl methyl piperazine derivative with potential activity against tuberculosis: Application to drug development.
Magotra A; Sharma A; Gupta AP; Wazir P; Sharma S; Singh PP; Tikoo MK; Vishwakarma RA; Singh G; Nandi U
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():200-206. PubMed ID: 28623772
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of sensitive and selective LC-MS/MS methods for the determination of BMS-708163, a gamma-secretase inhibitor, in plasma and cerebrospinal fluid using deprotonated or formate adduct ions as precursor ions.
Gu H; Deng Y; Wang J; Aubry AF; Arnold ME
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(25):2319-26. PubMed ID: 20674522
[TBL] [Abstract][Full Text] [Related]
16. Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantification of Olorofim (F901318), a Novel Antifungal Drug, in Human Plasma and Serum.
Müller C; Fietz C; Koehler P; Sibley G; Nforbugwe ACA; Streichert T; Wiesen MHJ
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150474
[TBL] [Abstract][Full Text] [Related]
17. Drugging ATR: progress in the development of specific inhibitors for the treatment of cancer.
Foote KM; Lau A; Nissink JW
Future Med Chem; 2015; 7(7):873-91. PubMed ID: 26061106
[TBL] [Abstract][Full Text] [Related]
18. Microdose clinical trial: quantitative determination of fexofenadine in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry.
Yamane N; Tozuka Z; Sugiyama Y; Tanimoto T; Yamazaki A; Kumagai Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):118-28. PubMed ID: 17804306
[TBL] [Abstract][Full Text] [Related]
19. A simplified protein precipitation/mixed-mode cation-exchange solid-phase extraction, followed by high-speed liquid chromatography/mass spectrometry, for the determination of a basic drug in human plasma.
Xue YJ; Akinsanya JB; Liu J; Unger SE
Rapid Commun Mass Spectrom; 2006; 20(18):2660-8. PubMed ID: 16912986
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of naltrexone and 6beta-naltrexol in human, rat, and rabbit plasma by liquid chromatography-electrospray ionization tandem mass spectrometry with application to the pharmacokinetics of Depotrex in rabbits.
Slawson MH; Chen M; Moody D; Comer SD; Nuwayser ES; Fang WB; Foltz RL
J Anal Toxicol; 2007 Oct; 31(8):453-61. PubMed ID: 17988459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
